Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion type Assertion NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_head.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion wasGeneratedBy ECO_0000203 NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_provenance.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion wasDerivedFrom befree-20140225 NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_provenance.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion SIO_000772 24011934 NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_provenance.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion evidence source_evidence_literature NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_provenance.
- NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_assertion description "[Dysregulation of the phosphoinositide 3-kinase/mammalian target of rapamycin (PI3K/mTOR) and RAS/extracellular signal-regulated kinase (ERK) pathways is common in ovarian cancer, providing potential new targets for 2nd line therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP372986.RARhVJvDRmDuLsIBLDKVh3_trosxVmM5tEr6fECs3IGnw130_provenance.